LONG-TERM RESULTS OF DEEP SCLERECTOMY IN NORMAL-TENSION GLAUCOMA

Slides:



Advertisements
Similar presentations
Outcome of 23-gauge sutureless transconjunctival vitrectomy for endophthalmitis Dr Colin S.H. Tan.
Advertisements

Trabeculectomy + MMC Audit Mark Chiang, Clinical Research Fellow Mr. Peter Shah, Consultant Ophthalmic Surgeon Good Hope Hospital.
Use of a Novel Y- Suture Technique to Reduce Detachments in Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) Habeeb Ahmad, MD Martin Heur,
Early Outcomes of Descemet’s Stripping Automated Endothelial Keratoplasty in Pseudophakic Eyes with Anterior Chamber Intraocular Lenses Preeya K. Gupta.
Phacoemulsification with Goniosynechialysis in the Management of Refractory Acute Angle-closure Glaucoma Ghasem Fakhraie*, MD, Mahmoud Jabbarvand, MD,
Dr. K.S.SIDDHARTHAN Aravind Eye Hospital Coimbatore
Somasheila I. Murthy, Prashant Garg, Pravin K. Vaddavalli
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Trabeculectomy for Open-Angle Glaucoma Takihara Y, Inatani M, Ogata-Iwao M, et.
TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?
Purpose: Introduction:  At initial evaluation: For post-op day # 0 patients: Pre-op VA was 20/50.6 (0.395 ± 0.198); Post-op VA was 20/102.0 (0.196 ± 0.162);
OCULAR HYPERTENSION AFTER PENETRATING KERATOPLASTY F Orucov, E Strassman, D Landau, J Frucht-Pery and A Solomon, Department of Ophthalmology, Hadassah-Hebrew.
>>0 >>1 >> 2 >> 3 >> 4 >> FULL PANRETINAL PHOTOCOAGULATION IMPROVES THE OUTCOME OF TRABECULECTOMY IN NEOVASCULAR GLAUCOMA Saleh alobeidan MD Essam osman.
Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
HEFT Audit Nov 2008 Trabeculectomy + Antiscarring Mitomycin C Prof Peter Shah Mr Aruna Dharmasena Dr Freda Sii.
Cataract Surgery After Trabeculectomy: The Effect on Trabeculectomy Function Husain R, Liang S, Foster PJ. Cataract surgery after trabeculectomy: the effect.
AlphaCor TM : A Novel Approach to Minimize Late Post-operative Complications V. Ngakeng MD, M. Price PhD. MBA, F. Price MD.
Combined Phacoemulsification and Ahmed Glaucoma Drainage Implant Surgery Leonidas Traipe, M.D. Felipe Valenzuela, M.D. Carlos Nieme, M.D Juan Stoppel,
1 Clinical Outcomes of DSEK Surgery Combined With Other Intraocular Procedures Neil Mahesh Vyas, MD Fei Yu, PhD Anthony J. Aldave, MD Sophie Deng, MD,
Phototoxic Maculopathy After Scleral Sutured IOL Implantation NC CHO, DW LEE, EY KWEON, MJ KIM Department of Ophthalmology, Chonbuk National University.
Endothelial Keratoplasty in Patients With an Anterior Chamber Intraocular Lens: A Montreal Experience Georges M. Durr, MD 1,2 Johanna Choremis, MD, FRCSC.
Introduction  Selective Laser Trabeculoplasty (SLT) uses a Q-Switched frequency- doubled (532 nm), low energy Nd:YAG laser, which targets melanocytes.
Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,
PHACO-TRAB VERSUS PHACO ONLY IN EYES WITH ADVANCED OR END-STAGE GLAUCOMA WITH CONTROLLED INTRAOCULAR PRESSURE AND VISUALLY SIGNIFICANT CATARACT Liaska.
Advanced Glaucoma and Cataract: Management Options Regenbogen Michael – Ichilov Amer Radgonde – Hadassah Ron Yonina – Beilinson Reyvitch Svetlana – Barsilai.
Ki-Cheol Chang, MD Department of Ophthalmology, Dankook University Hospital, South Korea Financial disclosure : Author has no commercial associations.
Sponsored by the National Eye Institute,
Angiofibrotic Response to Vascular Endothelial Growth Factor Inhibition in Diabetic Retinal Detachment: Report No. 1 Sohn EH, He S, Kim LA, et al. Angiofibrotic.
Efficacy and Safety of the Ex-PRESS Glaucoma Mini-Shunt with Intraoperative 5-Fluorouracil ASCRS 2009 – San Francisco A. Balashanmugam, MD, L. Farrokh-Siar,
4/3/2016 U F G Universidade Federal de Goiás C B C O Centro Brasileiro de Cirurgia de Olhos A Prospective, Comparative Study Between Endoscopic Cyclophotocoagulation.
Descemet’s Stripping Endothelial Keratoplasty (DSEK) in patients with prior Trabeculectomy or Tube shunt surgery. Thadani S.M. Fynn-Thompson N. Authors.
EFFICACY OF SUBCONJUCTIVAL BEVACIZUMAB ASSOCIATED TO MITOMYCIN-C ON GLAUCOMA FILTERING SURGERY. Juan Carlos Mesa-Gutiérrez, MD, PhD, FEBOphth, FICOphth.
Surgical Outcomes In Children With Primary Childhood Glaucoma
A Paul, C Louize,S Shafquat Dudley Hospitals NHS Foundation Trust
Pseudoexfoliation syndrom and cataract: results and complication frequency in immature and mature cataract surgery Marijana Bilen Babić Department of.
NonPenetrating Glaucoma Surgery
COMBINED PHACOEMULSIFICATION AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION
Assessment of Intraocular Pressure in patients treated with aflibercept Cristina Vendrell Gómez, Anna Puntí Badosa, Natalia Procházka Enrich, Antonia Sierra.
Andrés Suárez-Campo, María López-Valladares
IOP control and corneal endothelial cell density changes
IMAGINING OF INTRASCLERAL LAKE AFTER IMPLANTATION OF EX-PRESS MINI SHUNT DEVICE IN GLAUCOMA SURGERY USING VISANTE OPTICAL COHERENCE TOMOGRAPHY López-Caballero.
Selective laser trabeculoplasty in Korean eyes with medically uncontrolled pseudoexfoliation glaucoma Su Chan Lee1, Jung Hyun Lee1,
Nagasaki University, Nagasaki, Japan
Effect of Primary Phacoviscocanalostomy / Viscocanalostomy On Intraocular Pressure Of Normal Tension Glaucoma Patients: 3-Year Results Derek Ho¹, Adesuwa.
Macular Epiretinal membrane
V. Kumar,1,2 M. Frolov,1 E. Bozhok,2 G. Dushina1
Late In-the-bag Intraocular Lens Dislocation:
Early Intraocular Pressure Rise After Phacoemulsification In Non-Glaucomatous And Eyes With Primary Open-Angle Glaucoma Milos Todorovic 1, Suncica Sreckovic.
Trauma z Surgical treatment of extremely complicated forms of glaucoma
A NEW INTRACANALICULAR DEVICE TO TREAT OPEN-ANGLE GLAUCOMA
Effect of Selective Laser Trabeculoplasty on
TRABECULECTOMY Saleh Al Obeidan, MD Department of Ophthalmology
A presentation to: Meeting name Date
Preoperative Characteristics
Frolov Mikhail, Dushina Galina
Opacification of the optic of an Akeos Adapt® intraocular lens
Kyoto Prefectural University of Medicine
Randomized Clinical Trial Jeffrey G. Gross, M.D. for the DRCR Network
NonPenetrating Glaucoma Surgery
Early Experience with Descemet’s Stripping Automated Endothelial Keratoplasty Combined with Phacoemulsification: Clinical and Refractive Outcome University.
Winthrop University Hospital
Sarosh A. Janjua MD1, Sandra L. Cremers MD FACS1
Long term Results of Endothelial Keratoplasty in patients with failed penetrating Keratoplasty Maoz D. Amiran, MD, Raneen Shehadeh-Mashor, MD, Marie Eve.
Clinical study of open angle glaucoma surgery treatment trough deep slerectomy with T-Flux NV implant: three years follow-up Dr. Marco Rossi Dr Michele.
DW.Lee, NC Cho, MJ Kim, EY Kwen
Treatment Outcomes of Mitomycin C-Augmented Trabeculectomy, Sub-Tenon Injection versus Soaked Sponges, after 3 Years of Follow-up  Hamed Esfandiari, MD,
Japanese Red Cross Society
Royal Victorian Eye and Ear Hospital
Safety and Efficacy of Mapracorat Ophthalmic Suspension in the Treatment of Inflammation Following Cataract Surgery: Adaptive Design Study Timothy L.
Karen Chia, MD Chan Tat Keong, MD Peter Tseng, MD Doric Wong, MD
ASCRS 2010 Joseph A. Donnelly Albert Einstein College of Medicine
Presentation transcript:

LONG-TERM RESULTS OF DEEP SCLERECTOMY IN NORMAL-TENSION GLAUCOMA Mika Harju MD, Ph.D, Sakari Suominen, MD, Pasi Allinen, MD, Eija Vesti, MD, Ph.D* Department of Ophthalmology, University of Helsinki and Helsinki University Hospital *Department of Ophthalmology, University of Turku and Turku University Hospital INTRODUCTION To the best of our knowledge, there are only two reports on the efficacy of deep sclerectomy in studies that included NTG eyes only. Our previously published retrospective outcomes (1) encouraged us to do a prospective study on deep sclerectomy in NTG eyes randomised for MMC augmentation. The 1-year-results were reported previously (2) PURPOSE To study the long-term outcome of deep sclerectomy with and without Mitomycin-C (MMC) in normal-tension glaucoma (NTG) patients. METHODS We prospectively analysed consecutive patients randomized to surgery performed either with (MMC group) or without (non-MMC) MMC. Deep sclerectomy with a collagen implant was performed on all eyes. Surgery was considered totally successfully if, after surgery, the preoperative intraocular pressure (IOP) level was reduced by 25% without medication, and a qualified success if medication was required to achieve the same limits Failure were eyes with additional hypotensive surgery for glaucoma, IOP reduction <25% after surgery, loss of >2 lines of visual acuity unrelated to other ocular pathology, and IOP ≤ 4 mmHg together with reduced visual acuity, shallow anterior chamber, hypotony maculopathy, or choroidal effusion. RESULTS Enrolled were 37 patients (mean age 64 ± 7 years); 15 patients in the MMC group and 22 in the non-MMC group, and the mean ±SD follow-up time 7.2±1.7 (range 1.0-9.0) years. Needling was repeated more often in the non-MMC group; needling was performed a 0.5±0.8 times in the MMC group, and 1.4±1.6 times in the non-MMC group, (p=0.025). Needling with MMC injection was performed 0.2±0.4 times in the MMC group, and 1.1±1.4 times in the non-MMC group (P=0.005). At the 6- to 9-years follow-up, the overall (both groups together) complete and qualified success rates were 50% and 71%, with no significant difference between groups (p=0.48, and p=0.25). Four eyes had VA reduced by 2 lines or more. Three of them were in the MMC group and had other pathologies explaining their drop in visual acuity; 1 eye with ONH C/D 0.9-1.0 developed cataract, 1 eye had macular degeneration and preretinal fibrosis; 1 eye had diabetic maculopathy and vitreous traction, and was treated with vitrectomy and recurrent intra-vitreal injections with vascular endothelial growth factor inhibitors. One eye in the non-MMC group had VA acuity reduced from 1.0 to 0.63 in Snellen, and at least some cataract formation. Iris incarceration of the trabeculo-Descemet’s membrane was detectable in 4 of 15 (27%) in the MMC group, and in 8 of 22 (36%) in the non-MMC group (P=0.64). In all cases but one, the iris incarceration was treated with laser iridoplasty. ACKNOWLEDGEMENTS CONCLUSION Glaucoma Foundation LUX In NTG, long-term significant IOP reduction can be achieved with deep sclerectomy with a low incidence of sight-threatening complications. Mary and Georg C. Ehrnrooth Foundation We accounted no cases of hyphema, shallow anterior chamber, hypotony maculopathy, choroidal effusion, late bleb leakage, blebitis, endophthalmitis, or malignant glaucoma. Finnish Eye Foundation CORRESPONDENCE To mika.harju@hus.fi. MMC augmentation resulted in lower IOP up to 5 years post-operatively, but the difference between the groups attenuated because of higher frequencies of goniopunctures and needling procedures in the non-MMC group. 1. Suominen S, Harju M, Ihanamäki T, Vesti E. The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results. Acta Ophthalmol 2010;88:27-32. 2. Suominen S, Harju M, Kurvinen L & Vesti E. Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c. Acta Ophthalmol 2014;92:701–6. Fig 1 Fig 2 Cumulative survival of the total (Fig 1) and qualified (Fig 2) success in mitomycin-C (MMC) and non-MMC groups. Difference between groups not significant (p=0.23, and p=0.13).